Ampio Pharmaceuticals: Overhyped And Undercapitalized

News: Ampio Pharmaceuticals: Overhyped And Undercapitalized

Time: Thursday, February 22, 2018 15:14


Intraday Maximum Change: $-0.315 - -13.73% Minutes After: 19

Latest Quote: 2.23 Change Since: $-0.38 - -17.04% Days Since: 146

Snapshot of company's key stats at the time of the event

Market Cap: 189,854,523 Shares Outstanding: 75,941,809 Float: 73,436,207

Day's Short Interest: 11,053,802 Short Ratio: 7.19%

Institutional Ownership: 14.2% Insider Ownership: 0%

AMPE - Ampio Pharmaceuticals Inc.

Sector: Healthcare - Industry: Biotechnology

Ampio Pharmaceuticals Inc is a biopharmaceutical company. The company is engaged in the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options.